Infertility

Gast, MD, PhD to Lead Clinical Research and Development TODAY ON PHARMALIVE.COM Genaera Appoints Michael J.

Gast, MD, PhD to Lead Clinical Research and Development PLYMOUTH MEETING, Pa., March 21, 2006 /PRNewswire-FirstCall/ - Genaera Corporation today announced the appointment of Michael J.

Gast, MD, PhD, as Senior Vice President, Clinical Research and Development.

Dr.

Gast served as Chief Medical Officer of Genaera during the first half of 2005 and left briefly to pursue personal interests.

He has been a full-time consultant to the Company since November of 2005.

"We are very pleased to have Mike return to the Genaera management team," said Jack Armstrong, President and CEO of Genaera Corporation.

"Mike's guidance has been invaluable as we have adapted and refined our clinical strategy for EVIZON(TM) (squalamine lactate) over the past year.

In his new role he will provide strong leadership and essential expertise for the next development phase of this product and all of our programs moving forward.

His appointment is part of my commitment to expanding our management and advisory resources in areas critical to our success." "This is an exciting time for Genaera, and I'm pleased to be rejoining this talented and committed team," said Dr.

Gast.

"I'm very enthusiastic about the clinical potential of each of the drug candidates in our broad development portfolio, particularly EVIZON, which I believe represents a unique and highly diffe...

Read more...